Početna stranica539523 • BOM
add
Alkem Laboratories Ltd
Preth. zaklj. cijena
4.750,35 ₹
Dnevni raspon
4.686,80 ₹ - 4.772,60 ₹
Godišnji raspon
4.409,90 ₹ - 6.440,00 ₹
Tržišna kapitalizacija
559,73 mlr. INR
Prosječna količina
3,52 tis.
P/E omjer
26,02
Prinos dividende
0,90 %
Glavno tržište vrijednosnica
NSE
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(INR) | pro 2024.info | Godišnja promjena |
---|---|---|
Prihod | 33,74 mlr. | 1,52 % |
Operativni troškovi | 14,96 mlr. | 8,29 % |
Neto dohodak | 6,26 mlr. | 5,19 % |
Neto profitabilnost | 18,55 | 3,63 % |
Zarada po dionici | 52,34 | −2,59 % |
EBITDA | 7,39 mlr. | 4,74 % |
Efektivna porezna stopa | 12,35 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(INR) | pro 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 22,89 mlr. | −36,59 % |
Ukupna imovina | — | — |
Ukupne obveze | — | — |
Ukupni kapital | 119,10 mlr. | — |
Dionice u optjecaju | 119,57 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 4,94 | — |
Povrat imovine | — | — |
Povrat kapitala | 12,59 % | — |
Tok novca
Neto promjena novca
(INR) | pro 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | 6,26 mlr. | 5,19 % |
Gotovina od poslovanja | — | — |
Gotovina iz ulaganja | — | — |
Gotovina iz financiranja | — | — |
Neto promjena novca | — | — |
Slobodan tok novca | — | — |
Više
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Osnovano
1973
Sjedište
Web-lokacija
Zaposlenici
17.432